Nuray BİLGE, Mustafa CEYLAN, Ahmet YALCİN, Omer Lutfi GUNDOGDU

Association between biomarkers in the long-term prognosis of ischemic stroke

Aim: Predicting of the stroke prognosis has utmost importance as the disease has a heavy socioeconomical burden. For thisreason, instruments such as stroke severity scales, stroke volume calculations and various biomarkers are used for determinationof prognosis. NIHS scale, stroke volume, stroke type, neutrophil/lymphocyte ratio and C-reactive protein levels were reported to beassociated with stroke prognosis. In this study we aim to investigate the relationship between these parameters with 8-year-survivalfrom stroke.Materials and Methods: Between January 2010 and January 2012, all patients aged over 18 and diagnosed with arterial stroke wereretrospectively investigated. Data regarding survival status were obtained from Death Reporting System (https://obs.gov.tr/) underthe surveillance of Ministry of Health. NIHS scale, stroke volume, stroke subtype, neutrophil/lymphocyte ratio and C- reactive proteinlevels were obtained and compared in deceased and living patients and association between those parameters and survival wassought.Results: Advanced age, male gender, NIHS scale, stroke volume, stroke subtype, neutrophil/lymphocyte ratio were associated withstroke survival. C-reactive protein levels were not be found associated.Conclusion: Our results were consistent with the literature and, NIHS scale, stroke volume, stroke subtype, neutrophil/lymphocyteratio predicted the stroke prognosis. As there is not enough data present in the literature, our findings were remarkable.

PDF

___

1. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2013;44:2064-89.
2. Bender M, Jusufovic E, Railic V, et al. High Burden of Stroke Risk Factors In Developing Country: The Case Study Of Bosnia-Herzegovina. Mater Sociomed 2017;29:277-9.
3. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
4. Onat A, Hergenc G, Can G. Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition. Anatol J Kardiol 2007;7:29-34.
5. Sajobi TT, Menon BK, Wang M, et al. Early Trajectory of Stroke Severity Predicts Long-Term Functional Outcomes in Ischemic Stroke Subjects: Results From the ESCAPE Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times). Stroke 2017;48:105-10.
6. Wang J, Yu XD, Li GQ. Comparative study on short-term and long-term prognostic determinants in patients with acute cerebral infarction. Int J Clin Exp Med 2015;8:9855-61.
7. Su YC, Huang KF, Yang FY, et al. Elevation of troponin I in acute ischemic stroke. Peer J. 2016; 4:1866.
8. Ceylan M, Yalcin A, Bayraktutan OF, et al. Serum pentraxin-3 levels in acute stroke: No association with stroke prognosis. Atherosclerosis 2015;243:616-20.
9. Domac FM, Somay G, Misirli H, et al. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke. Neurosciences (Riyadh) 2007;12:25-30.
10. VanGilder RL, Davidov DM, Stinehart KR, et al. C-reactive protein and long-term ischemic stroke prognosis. J Clin Neurosci 2014;21:547-53.
11. Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638-43.
12. Tokgoz S, Keskin S, Kayrak M, et al. Is neutrophil/lymphocyte ratio predict to short-term mortality in acute cerebral infarct independently from infarct volume? J Stroke Cerebrovasc Dis 2014;23:2163-8.
13. Khera A, de Lemos JA, Peshock RM, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006;113:38-43.
14. Di Napoli M, Papa F, Bocola V. C-Reactive Protein in Ischemic Stroke: An Independent Prognostic Factor. Stroke 2001;32:917-24.
15. Wilson PW, Nam BH, Pencina M, et al. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med 2005;165:2473-8.
16. D. Lloyd-Jones, R. Adams, M. Carnethon, et al. Heart disease and stroke statisticse 2009 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 2009;119:480-6.
17. Utku U, Çelik Y. Strokta Etyoloji, Sınıflandırma ve Risk Faktörleri. Serebrovasküler Hastalıklar ed. Balkan S, editor. Antalya: Güneş Kitapevi; 2005;57-71.
18. T. Brott, J.R. Marler, C.P. Olinger, et al. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke 1989; 20:871-5.
19. Mar J, Masjuan J, Oliva-Moreno J, et al. Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain, HealthQual. Life Outcomes 2015; 13:36.
20. Wei W, Li S, San F, et al. Retrospective analysis of prognosis and risk factors of patients with stroke by TOAST. Medicine (Baltimore) 2018;97:0412.
21. Hsu CY, Hu GC, Chen YM, et al. Predictors of short- and longterm mortality in first-ever ischaemic older stroke patients. Australas J Ageing 2013;32:229-32
22. Staaf G, Lindgren A, Norrving B. Pure motor stroke from presumed lacunar infarct: long-term prognosis for survival and risk of recurrent stroke. Stroke 2001;32:2592-6.
23. Varona JF, Bermejo F, Guerra JM, et al. Long-term prognosis of ischemic stroke in young adults. Study of 272 cases. J Neurol 2004;251:1507-14.
24. Bang OY, Park HY, Yoon JH, et al. Predicting the Long-Term Outcome after Subacute Stroke within the Middle Cerebral Artery Territory. J Clin Neurol 2005;1:148-58.
25. Zaidi SF, Aghaebrahim A, Urra X, et al. Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy. Stroke 2012;43:3238-44.
26. Redfors P, Jood K, Holmegaard L, Rosengren A, Blomstrand C, Jern C. Stroke subtype predicts outcome in young and middleaged stroke sufferers. Acta Neurol Scand2012;126:329-35.
27. K.B. Slot, E. Berge, P. Dorman, et al. Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies, BMJ 2008;336:376-9
28. Chu LM, Liu CC, Yeh CC, et al. Increased diabetes risk and interaction with social and medical events in patients upon stroke: Two nationwide studies. Atherosclerosis 2017;265:87-92.
29. Castro HHG, Alencar AP, Benseñor IM, et al. Multimorbidities Are Associated to Lower Survival in Ischaemic Stroke: Results from a Brazilian Stroke Cohort (EMMA Study). Cerebrovasc Dis 2017;44:232-9.
30. Papa A, Emdin M, Passino C, et al. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008;395:27-31.
31. Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 2007;154:995-1002.
32. Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010;106:470-6.
33. Muhmmed Suliman MA, Bahnacy Juma AA, Ali Almadhani AA, et al. Predictive value of neutrophil to lymphocyte ratio in outcomes of patients with acute coronary syndrome. Arch Med Res 2010;41:618-22.
34. Balestrino M, Partinico D, Finocchi C, Gandolfo C. White blood cell count and erythrocyte sedimentation rate correlate with outcome in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 1998;7:139-44.
35. Christensen H, Boysen G. C-reactive protein and white blood cell count increases in the first 24 hours after acute stroke. Cerebrovasc Dis 2004;18:214-9.
36. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
37. Zhang YX, Cliff WJ, Schoefl GI, et al. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 1999;145:375-9.
38. Gussekloo J, Schaap MCL, Frolich M, et al. C-Reactive Protein Is a Strong but Nonspecific Risk Factor of Fatal Stroke in Elderly Persons. Arterioscler Thromb Vasc Biol 2000;20:1047-51.